SAN DIEGO, Jan. 25, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary KannawayLLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is holding an exclusive Roadshow Event in Phoenix, AZ this Saturday. The Roadshow Event provides a unique opportunity to
Attendees will hear from executive team members, including Kannaway® CEO Blake Schroeder, President Brad Tayles and CEO of Kannaway® parent company Medical Marijuana, Inc. Dr. Stuart Titus.
"Our Roadshow events are designed to help people understand what it takes to become successful with Kannaway from leading Brand Ambassadors and learn about the unique opportunities Kannaway can offer them," said Kannaway® CEO Blake Schroeder.
"We love that we are able to share our company's growth with so many new and seasoned Brand Ambassadors," Schroeder continued. "In 2017, Kannaway had its largest revenue year in company history, experiencing year-over-year revenue growth of more than 255% compared to 2016 and we plan to continue growing exponentially in 2018."
The Phoenix Roadshow Event is scheduled from 1 - 4 p.m. MST on Saturday, Jan. 27, at the Sheraton Crescent Hotel. Advance tickets are available now for just $30, the price of tickets will increase to $40 at the door.
Please visit here to learn more about the Kannaway® Phoenix, AZ Roadshow Event and to purchase tickets.
About Kannaway, LLC
Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT:Public Relations Contact:Andrew HardChief Executive Officer CMW MediaP. email@example.com
View original content:http://www.prnewswire.com/news-releases/medical-marijuana-inc-subsidiary-kannaway-announces-exclusive-roadshow-event-in-phoenix-az-300588121.html
SOURCE Medical Marijuana, Inc.
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All